171 related articles for article (PubMed ID: 37713832)
41. A Comprehensive Analysis of the Prognostic, Immunological and Diagnostic Role of CCNF in Pan-cancer.
Gao X; Bu H; Ge J; Gao X; Wang Y; Zhang Z; Wang L
J Cancer; 2023; 14(13):2431-2442. PubMed ID: 37670965
[No Abstract] [Full Text] [Related]
42. Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas.
Wei C; Wang B; Peng D; Zhang X; Li Z; Luo L; He Y; Liang H; Du X; Li S; Zhang S; Zhang Z; Han L; Zhang J
Front Immunol; 2022; 13():849592. PubMed ID: 35444654
[TBL] [Abstract][Full Text] [Related]
43. Pan-Cancer Analysis of the Oncogenic and Immunological Role of
Ding J; Meng Y; Han Z; Luo X; Guo X; Li Y; Liu S; Zhuang K
Front Oncol; 2022; 12():811567. PubMed ID: 35651805
[TBL] [Abstract][Full Text] [Related]
44. Biological and immunological significance of DLL3 expression in different tumor tissues: a pan-cancer analysis.
Zhang Y; Shang L; Han J; Shen X; Liu H; Yang J; Shi H
Aging (Albany NY); 2023 Apr; 15(9):3427-3441. PubMed ID: 37179118
[TBL] [Abstract][Full Text] [Related]
45. Oncogenic role of copper‑induced cell death‑associated protein DLD in human cancer: A pan‑cancer analysis and experimental verification.
Qi H; Zhu D
Oncol Lett; 2023 May; 25(5):214. PubMed ID: 37123026
[TBL] [Abstract][Full Text] [Related]
46. ANXA2 is a potential biomarker for cancer prognosis and immune infiltration: A systematic pan-cancer analysis.
Ning Y; Li Y; Wang H
Front Genet; 2023; 14():1108167. PubMed ID: 36713082
[No Abstract] [Full Text] [Related]
47. IMPDH1, a prognostic biomarker and immunotherapy target that correlates with tumor immune microenvironment in pan-cancer and hepatocellular carcinoma.
Liu C; Zhang W; Zhou X; Liu L
Front Immunol; 2022; 13():983490. PubMed ID: 36618420
[TBL] [Abstract][Full Text] [Related]
48. LncRNA WAC-AS1 expression in human tumors correlates with immune infiltration and affects prognosis.
Wang Y; Gong H; Cao Y
Hereditas; 2023 May; 160(1):26. PubMed ID: 37248547
[TBL] [Abstract][Full Text] [Related]
49. Chromobox Homolog 8 (CBX8) in Human Tumor Carcinogenesis and Prognosis: A Pancancer Analysis Using Multiple Databases.
Shi D; Ao L; Yu H; Xia Y; Li J; Zhong W; Xia H
Front Genet; 2021; 12():745277. PubMed ID: 34567093
[TBL] [Abstract][Full Text] [Related]
50. Potential value of PRKDC as a therapeutic target and prognostic biomarker in pan-cancer.
Yang X; Yang F; Lan L; Wen N; Li H; Sun X
Medicine (Baltimore); 2022 Jul; 101(27):e29628. PubMed ID: 35801800
[TBL] [Abstract][Full Text] [Related]
51. Comprehensive analysis of pan-cancer reveals the potential of SLC16A1 as a prognostic and immunological biomarker.
Chen L; Li Y; Deng X
Medicine (Baltimore); 2023 Mar; 102(11):e33242. PubMed ID: 36930112
[TBL] [Abstract][Full Text] [Related]
52. Pan-cancer analysis combined with experiments predicts CTHRC1 as a therapeutic target for human cancers.
Peng D; Wei C; Zhang X; Li S; Liang H; Zheng X; Jiang S; Han L
Cancer Cell Int; 2021 Oct; 21(1):566. PubMed ID: 34702252
[TBL] [Abstract][Full Text] [Related]
53. A Comprehensive Pan-Cancer Analysis of the Tumorigenic Role of Matrix Metallopeptidase 7 (MMP7) Across Human Cancers.
Meng N; Li Y; Jiang P; Bu X; Ding J; Wang Y; Zhou X; Yu F; Zhang Y; Zhang J; Xia L
Front Oncol; 2022; 12():916907. PubMed ID: 35785154
[TBL] [Abstract][Full Text] [Related]
54. Prognostic value of COL10A1 and its correlation with tumor-infiltrating immune cells in urothelial bladder cancer: A comprehensive study based on bioinformatics and clinical analysis validation.
Wang X; Bai Y; Zhang F; Li D; Chen K; Wu R; Tang Y; Wei X; Han P
Front Immunol; 2023; 14():955949. PubMed ID: 37006317
[TBL] [Abstract][Full Text] [Related]
55. Identifying the oncogenic roles of FAP in human cancers based on systematic analysis.
Ma C; Xi S; Sun H; Zhang M; Pei Y
Aging (Albany NY); 2023 Jul; 15(14):7056-7083. PubMed ID: 37490719
[TBL] [Abstract][Full Text] [Related]
56. A Comprehensive Analysis of the Glutathione Peroxidase 8 (GPX8) in Human Cancer.
Ren Z; He Y; Yang Q; Guo J; Huang H; Li B; Wang D; Yang Z; Tian X
Front Oncol; 2022; 12():812811. PubMed ID: 35402257
[TBL] [Abstract][Full Text] [Related]
57. Comprehensive pan-cancer analysis of role of GPRASP1, associated with clinical outcomes, immune microenvironment, and immunotherapeutic efficiency in pancreatic cancer.
Du J; Chen Y; Liu G; Zeng Q; Zhou N; Du D
Pathol Res Pract; 2023 Mar; 243():154374. PubMed ID: 36801507
[TBL] [Abstract][Full Text] [Related]
58. Comprehensive Pan-Cancer Analysis of KIF18A as a Marker for Prognosis and Immunity.
Liu T; Yang K; Chen J; Qi L; Zhou X; Wang P
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830695
[TBL] [Abstract][Full Text] [Related]
59. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
[TBL] [Abstract][Full Text] [Related]
60. A comprehensively prognostic and immunological analysis of actin-related protein 2/3 complex subunit 5 in pan-cancer and identification in hepatocellular carcinoma.
Huang S; Sun L; Hou P; Liu K; Wu J
Front Immunol; 2022; 13():944898. PubMed ID: 36148220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]